구보경 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

최종업데이트 2022.11.09.

Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort
- J. Cachexia Sarcopenia Muscle, First published: 20 November 2022 | https://doi.org/10.1002/jcsm.13125
- 2022-11
- 의약학
- 한빛사논문
Long-term effect of PNPLA3 on the aggravation of nonalcoholic fatty liver disease in the biopsy-proven cohort
- Clin. Gastroenterol. Hepatol., Available online 18 February 2022 | https://doi.org/10.1016/j.cgh.2022.02.026
- 2022-02
- 의약학
- 한빛사논문
A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease
- Clin. Gastroenterol. Hepatol., Volume 20, Issue 3, March 2022, Pages 682-691.e8 | https://doi.org/10.1016/j.cgh.2021.04.038
- 2022-03
- 의약학
- 한빛사논문
Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
- J. Cachexia Sarcopenia Muscle, Volume12, Issue4 August 2021 | https://doi.org/10.1002/jcsm.12719
- 2021-08
- 의약학
- 한빛사논문
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
- J. Hepatol., Available online 4 September 2016 | http://dx.doi.org/10.1016/j.jhep.2016.08.019
- 2016-09
- 의약학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문